Search bioRxiv⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.64898/2026.10.19.758223

An open-source, 3D-printable droplet microfluidics platform with strobe-enhanced microscopy

Padilla-Huamantinco, P.·Hurtado-Labarca, M.·Nel, C.·Astudillo, T.·Araya, W.·Leon, J. J.·Reyes Arroyo, J. B.·Wenzel, T.
View original source ↗Export metadata ↓

Abstract

Droplet microfluidics underpins many single-cell, precision biomedical, and nanomaterial techniques. However, implementing these methods reproducibly remains challenging outside specialised laboratories due to high equipment costs, operational inflexibility, mechanical impracticality at the microscope stage, as well as open-source pumping solutions that are inadequately validated for low-flow stability. We present an accessible, research-grade, open-source droplet microfluidics platform integrating a compact, microfluidics-optimised microscopy stage with networked syringe-pump control. Designed for local digital fabrication, primarily 3D printing, and widely available components, the platform supports reproducible builds across diverse settings. This setup enables stable droplet generation, observation of rapid droplet dynamics, and automation-ready networked workflows. The microscopy module uses a Raspberry Pi camera and microsecond stroboscopic illumination to capture sharp images of fast-moving droplets without the need for a high-speed camera. A modular hardware interface and extensible, web-accessible software stack provide a path to integrate additional modules and laboratory automation beyond the configuration evaluated here. For infusion, we introduce an open-source syringe pump optimised for low reliable flow rather than maximum rates, combining gearbox-assisted stepper mechanics with workflow-centric control that enables manual intervention (keypad control) and remote operation (web interface and automation hooks). We benchmark droplet regimes, size tuning, and time-stability under low-flow conditions (between 25 and 2500 uL/h) relevant to advanced assays and demonstrate biomedical readiness through the encapsulation and incubation of cells, beads, and bacteria in monodisperse droplets. The platform has been replicated across laboratories in Latin America and globally, including independent builds, supporting reproducibility. All design files, firmware/software, analysis notebooks, and benchmark datasets are openly released.

Explore related subjects

bioengineeringPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Padilla-Huamantinco, P., Hurtado-Labarca, M., Nel, C., Astudillo, T., Araya, W., Leon, J. J., Reyes Arroyo, J. B., Wenzel, T.. 2026-10-24. An open-source, 3D-printable droplet microfluidics platform with strobe-enhanced microscopy. https://doi.org/10.64898/2026.10.19.758223

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

Mesoscale Soft Robotics for Mechanically Perturbing and Functionally Monitoring Responses in Human Organoids

Human organoids represent promising models for studies of significance to the biology and medical communities. Of the existing approaches for monitoring organoids, none offers the ability to apply programmable mechanical forces while simultaneously recording multi-modal physiological responses, of relevance to phenomena spanning from traumatic brain injuries to cardiac rhythm disorders. Here, we present a mesoscale soft robotic organoid interface that enables programmable delivery of forces to organoids of diverse shapes, and to map electrophysiological activity and mechanical responses. The platform combines actuation elements with integrated sensors for quantitative measurement and control. Studies using this technology reveal that spheroidal cortical organoids exhibit distinct responses to mechanical trauma, including silencing, recovery, and changes in neuronal firing patterns. Additional experiments on cardiac ring tissues demonstrate that sustained stretching induces beat-to-beat rhythm variability and altered conduction. The results establish a framework for investigating force-triggered transitions between physiological and disease-like states in human tissue models.

bioengineering↗
bioRxiv2026

Few-shot regulatory sequence design with a genomic language model

A central challenge in generative biology is translating knowledge learned from natural sequences and experiments into designs with desired functions. In-context learning (ICL) is an emergent capability of large language models that allows them to adapt to new tasks from a few examples without additional training, enabling these models to become general-purpose learners. Here, we show that the genome language model, Evo 2, exhibits generative ICL in biological sequence design. Prompting with just tens of examples conditions Evo 2 to generate novel and diverse regulatory DNA sequences without any additional training. Mechanistic analysis suggests that genomic ICL may originate from induction, similar to phenomena observed in natural language. Reinforcement learning leveraging sequence-to-function models as experiment-derived rewards further strengthens ICL. We first validate this approach by generating enhancers that drive cell-type-specific gene expression in three human cell lines. Extending this approach in vivo, enhancers designed using human regulatory element data selectively label layer 5 extratelencephalic neurons in the mouse cortex with high specificity and stronger activity than existing enhancers. Our study provides evidence of emergent properties in genomic sequence models and introduces a promising approach for improving functional conditioning in generative biology.

bioengineering↗
bioRxiv2026

IOP-independent treatment for neurodegeneration in glaucoma using optimized ROS-scavenging microparticles for sustained release of erythropoietin

Glaucoma is a slow-progressing neurodegenerative disease of the optic projection to the brain and a leading cause of blindness worldwide. Current treatments are targeted towards lowering intraocular pressure (IOP), the only known, modifiable risk factor; however, this strategy is ineffective in many patients. An early hallmark of glaucomatous neurodegeneration is increased reactive oxygen species (ROS), representing an alternative opportunity for intervention to halt or slow disease progression. In this work, we optimize a ROS-scavenging copolymer, poly(propylene sulfide-co-ethylene sulfide) (PPSES), for formulation of size-controlled, stabilized, antioxidant microparticles (MPs) for sustained release of the protein erythropoietin (EPO). EPO promotes biological antioxidant defense via activation of NRF2-mediated transcription of antioxidant genes. This MP system overcomes the short half-life of EPO and leverages the combined benefits of bioactive EPO with long-lasting, inherently antioxidant PPSES MPs. The lead EPO-MP formulation preserves neurons in both mouse and non-human primate models of glaucoma through suppression of oxidative stress and optic nerve degeneration. EPO-loaded PPSES MPs represent a translationally relevant therapy for long-term management of glaucoma independent of IOP.

bioengineering↗